Varicella vaccination in Australia

Journal of Paediatrics and Child Health

Volumn 41, Issue 11, 2005, Pages 544-552

  Macartney, K K ^a,c   Beutels, P ^a,b   McIntyre, P ^a   Burgess, M A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Herpes zoster; Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

AUSTRALIA; CHICKENPOX; COST EFFECTIVENESS ANALYSIS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; FEVER; HERPES ZOSTER; HUMAN; INJECTION SITE REACTION; PRIORITY JOURNAL; RASH; REVIEW; UNITED STATES; VACCINATION; VARICELLA ZOSTER VIRUS; ADOLESCENT; CHILD; COST BENEFIT ANALYSIS; ECONOMICS; INCIDENCE; INFANT; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; SAFETY; TREATMENT OUTCOME;

ADOLESCENT; AUSTRALIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; COST-BENEFIT ANALYSIS; HERPES ZOSTER; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; NATIONAL HEALTH PROGRAMS; SAFETY; TREATMENT OUTCOME;

EID: 33644838949     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2005.00717.x     Document Type: Review

References (71)

1. National Health and Medical Research Council. Australian Immunisation Handbook, 8th edn. Canberra : Australian Government Department of Health and Ageing, 2003.
2. Gilbert GL, Gidding HF, Backhouse J, McIntyre PB. Varicella seroprevalence and vaccine uptake in preschool children. Med. J. Aust. 2005 182 : 42.
3. Gershon AA, Takahashi M, Seward J. Varicella vaccine. In : Plotkin SA, Orenstein WA, Offit PA (eds). Vaccines. Pennsylvania : W.B. Saunders, 2004 783 823.
4. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J. Infect. Dis. 1995 172 : 706 12.
5. Carapetis JR, Russell DM, Curtis N. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine 2004 23 : 755 61.
6. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases. Lancet 1994 343 : 1548 51.
7. Forrest J, Mego S, Burgess M. Congenital and neonatal varicella in Australia. J. Paediatr. Child Health 2000 36 : 108 13.
8. Centers for Disease Control and Prevention. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 1996 45 : 1 36. Recommendations and Reports.
9. Hope-Simpson RE. The nature of herpes zoster: A long-term study and a new hypothesis. Proc. R. Soc. Med. 1965 58 : 9 20.
10. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. (Published erratum appears in N. Engl. J. Med. 2000 Apr 6; 342 (14): 1063.) N. Engl. J. Med. 2000 342 : 635 45.
11. Hambleton S, Gershon AA. Preventing varicella-zoster disease (Review; 149 refs). Clin. Microbiol. Rev. 2005 18 : 70 80.
12. Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol. Infect. 2003 131 : 1085 89.
13. Chant KG, Sullivan EA, Burgess MA et al. Varicella-zoster virus infection in Australia Published erratum appears in Aust. N.Z. J. Public Health 1998 Aug; 22 (5): 630.) Aust. N.Z. J. Public Health 1998 22 : 413 18.
14. MacIntyre CR, Chu CP, Burgess MA. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol. Infect. 2003 131 : 675 82.
15. Brotherton J, McIntyre P, Puech M et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Commun. Dis. Intell. 2004 28 (Suppl 2 vii S116.
16. Kuter B, Matthews H, Shinefield H et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr. Infect. Dis. J. 2004 23 : 132 37.
17. Burgess MA, Cossart YE, Wilkins TD, Botham S, Fearns G, Chitour K. Varicella vaccination of health-care workers. Vaccine 1999 17 : 765 9.
18. Marshall H, Ryan P, Roberton D. Uptake of varicella vaccine - a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine 2005 in press).
19. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: Retrospective survey and systematic review. (Published erratum appears in BMJ 2000 Feb 5; 320 (7231): 361.) [Review] BMJ 1999 319 : 1462 7.
20. Milledge JT, Cooper CD, Woolfenden S. Barriers to immunization: Attitudes of general practitioners to varicella, the disease and its vaccine. J. Paediatr Child Health 2003 39 : 368 71.
21. Gershon AA. Varicella vaccine: Rare serious problems - but the benefits still outweigh the risks [Comment]. J. Infect. Dis. 2003 188 : 945 7.
22. Centers for Disease Control and Prevention (CDC). Prevention of varicella: Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 1999 48 : 1 5. Recommendations and Reports.
23. Centers for Disease Control and Prevention (CDC). National, state, and urban area vaccination coverage among children aged 19-35 months - United States, 2003. MMWR Morb. Mortal. Wkly. Rep. 2004 53 : 658 61.
24. Centers for Disease Control and Prevention (CDC). Vaccination coverage among children entering school - United States, 2003-04 school year. MMWR Morb. Mortal. Wkly. Rep. 2004 53 : 1041 44.
25. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004 114 : 786 92.
26. McCoy L, Sorvillo F, Simon P. Varicella-related mortality in California, 1988-2000. Pediatr. Infect. Dis. J. 2004 23 : 498 503.
27. Patel RA, Binns HJ, Shulman ST. Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. J. Pediatr. 2004 144 : 68 74.
28. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N. Engl. J. Med. 2005 352 : 450 8.
29. National Advisory Committee on Immunization. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI) statement on recommended use of varicella virus vaccine. Can. Commun. Dis. Rep. 1999 25 : 1 16.
30. Gustafson R, Skowronski DM. Disparities in varicella vaccine coverage in the absence of public funding. Vaccine 2005 23 : 3519 25.
31. Rentier B, Gershon AA, EuropeanWorking Group on Varicella. Consensus: Varicella vaccination of healthy children - a challenge for Europe. Pediatr. Infect. Dis. J. 2004 23 : 379 89.
32. Rasch G, Hellenbrand W. Germany adds varicella vaccine to the national vaccination programme. Eurosurveill. Wkly. 2004 8.
33. Asano Y. Varicella vaccine: The Japanese experience. J. Infect. Dis. 1996 174 (Suppl 3 S310 13.
34. Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: A household contact study. JAMA 2004 292 : 704 8.
35. Seward JF, Watson BM, Peterson CL et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002 287 : 606 11.
36. Vazquez M, LaRussa PS, Gershon AA et al. Effectiveness over time of varicella vaccine. JAMA 2004 291 : 851 5.
37. Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. An elementary school outbreak of varicella attributed to vaccine failure: Policy implications. J. Infect. Dis. 2004 190 : 477 83.
38. Dworkin MS, Jennings CE, Roth-Thomas J, Lang JE, Stukenberg C, Lumpkin JR. An outbreak of Varicella among children attending preschool and elementary school in Illinois. Clin. Infect. Dis. 2002 35 : 102 4.
39. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004 113 : 455 9.
40. Galil K, Lee B, Strine T et al. Outbreak of varicella at a day-care center despite vaccination. N. Engl. J. Med. 2002 347 : 1909 15.
41. Centers for Disease Control and Prevention (CDC). Outbreak of varicella among vaccinated children - Michigan, 2003. MMWR Morb. Mortal. Wkly. Rep. 2004 53 : 389 92.
42. Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin. Infect. Dis. 2002 34 : 774 9.
43. Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 1977 59 : 3 7.
44. Vazquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N. Engl. J. Med. 2001 344 : 955 60.
45. Galil K, Fair E, Mountcastle N, Britz P, Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J. Infect. Dis. 2002 186 : 102 5.
46. Verstraeten T, Jumaan AO, Mullooly JP et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics 2003 112 : e98 103.
47. Sharrar RG, LaRussa P, Galea SA et al. The postmarketing safety profile of varicella vaccine. Vaccine 2000 19 : 916 23.
48. Black S, Shinefield H, Ray P et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr. Infect. Dis. J. 1999 18 : 1041 6.
49. Wise RP, Salive ME, Braun MM et al. Postlicensure safety surveillance for varicella vaccine. (Published erratum appears in JAMA 2000 Dec 27; 284 (24): 3129.) JAMA 2000 284 : 1271 9.
50. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J. Infect. Dis. 2003 188 : 954 9.
51. Levy O, Orange JS, Hibberd P et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J. Infect. Dis. 2003 188 : 948 53.
52. Brisson M, Edmunds WJ, Gay NJ, Miller E. Varicella vaccine and shingles. JAMA 2002 287 : 2211 2.
53. Solomon BA, Kaporis AG, Glass AT, Simon SI, Baldwin HE. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). J. Am. Acad. Dermatol. 1998 38 : 763 5.
54. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: Implications for mass vaccination against chickenpox. Vaccine 2002 20 : 2500 7.
55. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: A case-control study. Lancet 2002 360 : 678 82.
56. Edmunds WJ, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J. Infect. 2002 44 : 211 19.
57. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol. Infect. 2000 125 : 651 69.
58. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J. Infect. Dis. 2005 191 : 2002 7.
59. Jumaan A, Schmid DS, Gargiullo P, Seward J. Scientific commentary. Vaccine 2004 22 : 3228 31.
60. Whitley RJ. Changing dynamics of varicella-zoster virus infections in the 21st century: The impact of vaccination. J. Infect. Dis. 2005 191 : 1999 2001.
61. Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 2005 352 : 2271 84.
62. Gilden DH. Varicella-zoster virus vaccine - grown-ups need it, too. N. Engl. J. Med. 2005 352 : 2344 46.
63. Thiry N, Beutels P, Van Damme P, Van Doorslaer E. Economic evaluations of varicella vaccination programmes: A review of the literature. Pharmacoeconomics 2003 21 : 13 38.
64. Thiry N, Beutels P, Tancredi F et al. An economic evaluation of varicella vaccination in Italian adolescents. Vaccine 2004 22 : 3546 62.
65. Brisson M, Edmunds WJ. The cost-effectiveness of varicella vaccination in Canada. Vaccine 2002 20 : 1113 25.
66. Brisson M. Modelling the impact of varicella-zoster virus vaccination (PhD Dissertation). London : City University, 2003.
67. Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia. Vaccine 1999 18 : 407 15.
68. Nolan T, McIntyre P, Roberton D, Descamps D. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Vaccine 2002 21 : 281 9.
69. White CJ, Stinson D, Staehle B et al. Measles, mumps, rubella, and varicella combination vaccine: Safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group. Clin. Infect. Dis. 1997 24 : 925 31.
70. Centers for Disease Control and Prevention (CDC) Varicella-related deaths - United States, January 2003-June 2004. MMWR Morb. Mortal. Wkly. Rep. 2005 54 : 272 4.
71. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: A 1-year survey. (Published erratum appears in Pediatrics 2004 May 5; 113 (5): 1470.) Pediatrics 2001 108 : E79.